Search research articles
Contact Us
Filters
Showing results (11-20 of 45) with videos related to
Page
of 5
Sort By:
Molecular Systems Biology
|
June 7, 2022
ENDORSE: a prognostic model for endocrine therapy in estrogen-receptor-positive breast cancers
Aritro Nath, Adam L Cohen, Andrea H Bild
BMC Biotechnology
|
August 26, 2016
Characterization of transcription factor response kinetics in parallel
Betul Bilgin, Aritro Nath, Christina Chan, et al.
Scientific Reports
|
October 2, 2015
Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma
Aritro Nath, Irene Li, Lewis R Roberts, et al.
Molecular Biology of the Cell
|
August 6, 2010
The double-stranded RNA-dependent protein kinase differentially regulates insulin receptor substrates 1 and 2 in HepG2 cells
Xuerui Yang, Aritro Nath, Michael J Opperman, et al.
Breast Cancer Research : BCR
|
March 30, 2024
Paradoxical cancer cell proliferation after FGFR inhibition through decreased p21 signaling in FGFR1-amplified breast cancer cells
Feng Chi, Jason I Griffiths, Aritro Nath, et al.
Frontiers in Molecular Biosciences
|
October 28, 2022
Predicting clinical response to everolimus in ER+ breast cancers using machine-learning
Aritro Nath, Patrick A Cosgrove, Jeffrey T Chang, et al.
Frontiers in Genetics
|
December 12, 2022
A machine learning framework for scRNA-seq UMI threshold optimization and accurate classification of cell types
Isaac Bishara, Jinfeng Chen, Jason I Griffiths, et al.
BMC Systems Biology
|
January 24, 2013
Signaling dynamics of palmitate-induced ER stress responses mediated by ATF4 in HepG2 cells
Hyunju Cho, Ming Wu, Linxia Zhang, et al.
Plos One
|
December 2, 2011
Synergy analysis reveals association between insulin signaling and desmoplakin expression in palmitate treated HepG2 cells
Xuewei Wang, Aritro Nath, Xuerui Yang, et al.
Cell Reports. Medicine
|
November 19, 2025
System analysis links SMARCD3 regulons to growth signaling and MEK inhibitor response in everolimus-resistant ER+ breast cancer cells
Eric F Medina, Elena Farmaki, Jason I Griffiths, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 45) with videos related to
Sort By:
Page
of 5
Molecular Systems Biology
|
June 7, 2022
ENDORSE: a prognostic model for endocrine therapy in estrogen-receptor-positive breast cancers
Aritro Nath, Adam L Cohen, Andrea H Bild
BMC Biotechnology
|
August 26, 2016
Characterization of transcription factor response kinetics in parallel
Betul Bilgin, Aritro Nath, Christina Chan, et al.
Scientific Reports
|
October 2, 2015
Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma
Aritro Nath, Irene Li, Lewis R Roberts, et al.
Molecular Biology of the Cell
|
August 6, 2010
The double-stranded RNA-dependent protein kinase differentially regulates insulin receptor substrates 1 and 2 in HepG2 cells
Xuerui Yang, Aritro Nath, Michael J Opperman, et al.
Breast Cancer Research : BCR
|
March 30, 2024
Paradoxical cancer cell proliferation after FGFR inhibition through decreased p21 signaling in FGFR1-amplified breast cancer cells
Feng Chi, Jason I Griffiths, Aritro Nath, et al.
Frontiers in Molecular Biosciences
|
October 28, 2022
Predicting clinical response to everolimus in ER+ breast cancers using machine-learning
Aritro Nath, Patrick A Cosgrove, Jeffrey T Chang, et al.
Frontiers in Genetics
|
December 12, 2022
A machine learning framework for scRNA-seq UMI threshold optimization and accurate classification of cell types
Isaac Bishara, Jinfeng Chen, Jason I Griffiths, et al.
BMC Systems Biology
|
January 24, 2013
Signaling dynamics of palmitate-induced ER stress responses mediated by ATF4 in HepG2 cells
Hyunju Cho, Ming Wu, Linxia Zhang, et al.
Plos One
|
December 2, 2011
Synergy analysis reveals association between insulin signaling and desmoplakin expression in palmitate treated HepG2 cells
Xuewei Wang, Aritro Nath, Xuerui Yang, et al.
Cell Reports. Medicine
|
November 19, 2025
System analysis links SMARCD3 regulons to growth signaling and MEK inhibitor response in everolimus-resistant ER+ breast cancer cells
Eric F Medina, Elena Farmaki, Jason I Griffiths, et al.
Page
of 5